Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly vs. Novo Nordisk: What's the Better Weight-Loss Stock to Buy?
08:15am, Thursday, 27'th Jul 2023
Eli Lilly has a couple of promising weight-loss treatments that could gain approval in the near future. Novo Nordisk's obesity care revenue doubled in the first quarter -- and stands to go still highe
3 Risky Stocks to Avoid at All Costs in 2023
02:26pm, Wednesday, 26'th Jul 2023
It's no secret that a few names have reached excessive valuations during the recent growth stocks rally. And so, they are overdue for a correction.
Is Eli Lilly Stock Still a Top-Growth Play?
02:40pm, Tuesday, 25'th Jul 2023
Eli Lilly has been a top performer over the past three years. Future appreciation will depend on how the competitive landscape in weight loss evolves.
Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush
08:46am, Monday, 24'th Jul 2023
Shares of Eli Lilly & Co. NYSE: LLY closed 2.80% higher for the week ended July 21, a week after Lilly said it would buy Versanis, a privately held clinical-stage biopharmaceutical company focused on
Lilly Joins Biogen as Alzheimer's Drugs Finally Emerge
08:03pm, Friday, 21'st Jul 2023
In trials, Biogen and Eli Lilly have shown that their drugs can slow early-stage decline in the disease. It could be a bonanza for patients—and investors.
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
05:05am, Friday, 21'st Jul 2023
Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
These 13 S&P 500 stocks stand out for expected growth through 2025
10:42am, Thursday, 20'th Jul 2023
As the 2023 stock-market rally continues, this is a good time to look further ahead to see which companies are expected to show the highest growth rates through 2025.
2 Healthcare Stocks That Could Join the $1 Trillion Club by 2033
10:00am, Thursday, 20'th Jul 2023
Eli Lilly and UnitedHealth Group have market caps in excess of $400 billion. Promising weight-loss treatments could generate significant growth for Eli Lilly.
My Take: 4 Strong Growth Stocks to Buy This Week
07:15am, Thursday, 20'th Jul 2023
Eli Lilly's emphasis on diabetes and obesity drugs sets it apart. Royal Caribbean is benefiting as people return to travel experiences.
At-home Alzheimer's testing is on the horizon, researchers say
08:04am, Wednesday, 19'th Jul 2023
A simple blood test of the type that can be done at home by a patient or family member has shown promise in detecting Alzheimer's, according to research released Wednesday at the Alzheimer's Associati
Eli Lilly's Alzheimer's drug slows cognitive decline: Study
05:31pm, Tuesday, 18'th Jul 2023
Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the latest study on the experimental drug, as well as Pfizer's partnership with Flagship Pioneering.
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
12:50pm, Tuesday, 18'th Jul 2023
Data from a phase III study shows that treatment with Eli Lilly's (LLY) donanemab slowed cognitive and functional decline by 60% in study participants at the earliest stage of Alzheimer's disease.
Biogen, Eli Lilly likely to split the Alzheimer's drug market, analysts say
08:39am, Tuesday, 18'th Jul 2023
Eli Lilly and Co. LLY, -0.52% and Biogen Inc. BIIB, -0.19% are likely to reach an “equitable split” of the Alzheimer's drug market after Lilly on Monday released more details on its late-stage tri
Is It Too Late to Buy Eli Lilly Stock?
05:26am, Tuesday, 18'th Jul 2023
Shares of Eli Lilly have soared 44% since the end of February. Eli Lilly's latest acquisition target was developing a drug that could work alongside Ozempic and related treatments.
Eli Lilly & Co study shows Alzheimer's drug slows memory decline
01:13pm, Monday, 17'th Jul 2023
Eli Lilly & Co revealed on Monday final results from its Phase 3 clinical study of donanemab at the Alzheimer's Association International Conference in Amsterdam, which showed that the antibody treatm
